Agnostic B cell selection approach identifies antibodies against K. pneumoniae that synergistically drive complement activation
Publication date
2024-12
Editors
Advisors
Supervisors
Document Type
Article
Metadata
Show full item recordCollections
License
cc_by_nc_nd
Abstract
Antibody-dependent complement activation plays a key role in the natural human immune response to infections. Currently, the understanding of which antibody-antigen combinations drive a potent complement response on bacteria is limited. Here, we develop an antigen-agnostic approach to stain and single-cell sort human IgG memory B cells recognizing intact bacterial cells, keeping surface antigens in their natural context. With this method we successfully identified 29 antibodies against K. pneumoniae, a dominant cause of hospital-acquired infections with increasing antibiotic resistance. Combining genetic tools and functional analyses, we reveal that the capacity of antibodies to activate complement on K. pneumoniae critically depends on their antigenic target. Furthermore, we find that antibody combinations can synergistically activate complement on K. pneumoniae by strengthening each other's binding in an Fc-independent manner. Understanding the molecular basis of effective complement activation by antibody combinations to mimic a polyclonal response could accelerate the development of antibody-based therapies against problematic infections.
Keywords
Antibodies, Bacterial/immunology, B-Lymphocytes/immunology, Complement Activation/immunology, Humans, Immunoglobulin G/immunology, Klebsiella pneumoniae/immunology, Memory B Cells/immunology, General Chemistry, General Biochemistry,Genetics and Molecular Biology, General Physics and Astronomy, Journal Article
Citation
van der Lans, S P A, Bardoel, B W, Ruyken, M, de Haas, C J C, Baijens, S, Muts, R M, Scheepmaker, L M, Aerts, P C, van 't Wout, M F L, Preiner, J, Marijnissen, R J, Schuurman, J, Beurskens, F J, Kerkman, P F & Rooijakkers, S H M 2024, 'Agnostic B cell selection approach identifies antibodies against K. pneumoniae that synergistically drive complement activation', Nature Communications, vol. 15, no. 1, 8100. https://doi.org/10.1038/s41467-024-52372-9, https://doi.org/10.1038/s41467-024-52372-9